drugset / Trial / NCT00343382

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

NCT00343382

RandomizedParallel-groupDouble-blindSupportive care

Summary

RATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a placebo in treating vaginal dryness in patients with breast cancer. PURPOSE: This randomized phase III trial is studying pilocarpine to see how well it works compared to a placebo in treating vaginal dryness in patients with breast cancer.

Timeline

Start
2006-12
Primary completion
2009-07
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown 5 mg Oral